Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1]
García Castelo A, Muñiz García J, Sesma Sánchez P, Castro Beiras A..
Grupo de estudio INCARGAL. Utilización de recursos diagnósticos y terapéuticos en pacientes ingresados por insuficiencia cardíaca: influencia del servicio de ingreso (estudio INCARGAL)..
Rev Esp Cardiol, (2003), 56 pp. 49-56
[2]
The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol. 1993;22 Suppl A:6-13.
[3]
Precipitating factors and decision-making processes of short-term worsening heart failure despite
[4]
Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E..
Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension..
J Am Coll Cardiol, (1993), 22 pp. 968-74
[5]
Stevenson LW, Perloff JK..
The limited reliability of physical signs for estimating hemodynamics in chronic heart failure..
JAMA, (1989), 10 pp. 884-8
[6]
Folland ED, Kriegel BJ, Henderson WG, Hammermeister KE, Sethi GK..
Implications of third heart sounds in patients with valvular heart disease. The Veterans Affairs Cooperative Study on Valvular Heart Disease..
N Engl J Med, (1992), 327 pp. 458-62
[7]
Mckee PA, Castelli WP, McNamara PM, Kannel WB..
The natural history of congestive heart failure: The Framingham study..
N Engl J Med, (1971), 285 pp. 1441-6
[8]
Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N, et al..
The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria..
Circulation, (1988), 77 pp. 607-12
[9]
Van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI..
Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy..
Am J Cardiol, (1992), 70 pp. 359-63
[10]
Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis. 6 ed. Boston: Little Brown and Co; 1964. p. 114.
[11]
En: Insuficiencia cardíaca: cuidado continuo. Guías, circuitos y educación del paciente. La Coruña: Congrega, S.L.; 2002.
[12]
Guidelines for the diagnosis and treatment of chronic heart failure..
Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology..
Eur Heart J, (2001), 22 pp. 1527-60
[13]
Rihal CS, Davis KB, Kennedy JW, Gersh BJ..
The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function..
Am J Cardiol, (1995), 75 pp. 220-3
[14]
Gillespie ND, McNeill G, Pringle T, Ogston S, Struthers AD, Pringle SD..
Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea..
BMJ, (1997), 314 pp. 936-40
[15]
Likoff MJ, Chandler SL, Kay HR..
Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy..
Am J Cardiol, (1987), 59 pp. 634-8
[16]
Badgett RG, Mulrow CD, Otto PM, Ramirez G..
How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med, (1996), 11 pp. 625-34
[17]
Miniati M, Pistolesi M, Paoletti P, Giuntini C, Lebowitz MD, Taylor AE, et al..
Objective radiographic criteria to differentiate cardiac, renal, and injury lung edema..
Invest Radiol, (1988), 23 pp. 433-40
[18]
Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al..
Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea..
N Engl J Med, (2004), 350 pp. 647-54
[19]
Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, et al..
Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally simptomatic left ventricular dysfunction..
Eur Heart J, (1999), 20 pp. 1799-807
[20]
Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, et al..
Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association..
Circulation, (1995), 92 pp. 3593-612
[21]
Grogan M, Smith HC, Gersh BJ, Wood DL..
Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy..
Am J Cardiol, (1992), 69 pp. 1570-3
[22]
AVID Investigators..
A Comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias..
N Engl J Med, (1997), 337 pp. 1576-83
